Abstract:
Introduction: Fibrocystic breast disease, commonly called fibrocystic breasts or fibrocystic change, is a benign (noncancerous)
condition, which is the most common pathology in women of reproductive age. Treatment of fibrocystic
breast disease and concomitant pathologies can involve using herbs.
Materials and Methods: To make an analysis of literary sources on the development of fibrocystic breast disease in
the pathogenesis of diseases of the female reproductive system (clinical human (75%) and animal studies (25%)) were
published in the period of 2017–2021.
Results and discussion: The diversity of plants in the world is a promising ground for therapeutic improvisation,
allowing for an individual approach to each patient, but, most importantly, creates possibilities for maneuvering in
the event of ineffectiveness of any means. In some situations, herbal medicine is not only possible or permissible, but
strictly mandatory, and is essentially the only effective therapeutic method, which is relatively safe provided the correct
selection of combinations and control by a doctor who applies a certain method of phytotherapy, especially given a
duration of treatment. The need for a deeper study is long overdue for the pharmacological capabilities of various plant
raw materials in the treatment of not only this pathology, but others as well.
Conclusion: The development of phytotherapy should be based primarily on scientific developments, but this area can
not be considered the prerogative of only phytotherapists, as herbal medicines should be in the arsenal of doctors of
all specialties.
